A r t i c l e s MHC proteins are an essential component of the adaptive immune system because of their role in presenting self and foreign processed peptides for inspection by T cells 1 . Human MHC genes-also referred to as HLA (human leukocyte antigen) genes-are extremely polymorphic, and variants of these genes have been associated with many traits, including most autoimmune diseases 2,3 . It has been suggested that in some cases the increased disease risk conferred by particular MHC alleles is due to differences in the peptides they present or to differences in the intrinsic stability of the MHC variants 4 . However, beyond the importance of these variants in shaping the sequence repertoire of antigenic peptides presented, in most cases, understanding of the functional implications of different MHC alleles and their interplay with TCR diversity is still limited 3,4 .
A r t i c l e s human cohort 29 for which both RNA-seq data from peripheral blood and genotyping data are available ( Fig. 1) . We took an undirected approach to testing, across the genome, for trans associations between genetic variation and expression of TCR V genes (we will also use the term 'bias' to refer to genotype-dependent shifts in V gene usage). Our results suggest that MHC genotypes have an important role in determining the V gene usage profiles of each individual's TCR repertoire.
RESULTS

Expression of TCR V genes is associated with MHC variation
We analyzed RNA-seq data collected from the peripheral blood of 922 individuals 29 of European ancestry. To estimate the relative expression of each V gene, we counted the number of reads that mapped uniquely to each V gene while controlling for the total expression of each TCR chain and other relevant covariates ( Fig. 1, Online  Methods, Supplementary Figs. 1 and 2, and Supplementary Table 1 ). After removing genes and individuals with low numbers of mapped reads, we had expression measurements for 44 V α , 40 V β , 11 V γ and 3 V δ genes in each of 895 individuals (Supplementary Figs. 3-5 and Supplementary Tables 2 and 3) . As ordinarily only one functional TCR is expressed for each T cell, estimated expression levels will be determined by the fraction of T cells expressing each TCR, as well as the expression level of the TCR in each cell. As a control, we applied a similar pipeline to analyze the V genes from B cell-secreted antibodies (immunoglobulins), which are not expected to interact with MHC.
To test for associations between genotype and the expression of TCR V genes, we used genome-wide genotype measurements in the same individuals 29 (Fig. 1) . We initially tested for short-range eQTLs, that is, ones within 1 Mb of each V gene. We excluded from this analysis a small number of genes in which read mappability varied across haplotypes (Online Methods and Supplementary Fig. 6 ). As expected, we found many short-range eQTLs, including for 78% of TCR V genes and 46% of immunoglobulin V genes at a 5% false discovery rate (FDR) ( Supplementary Fig. 7a and Supplementary Table 4 ), presumably reflecting cis-acting effects on gene regulation. We next tested across the genome for long-range eQTLs. Notably, we found multiple highly significant associations between the MHC locus and expression of TCR V genes. Expression of 47.7% and 22.5% of the V α and V β genes, respectively, was associated at a stringent threshold of P < 5 × 10 −8 , which accounts for genome-wide significance testing ( Fig. 2a,b, Supplementary Fig. 8 and Supplementary Table 5 ).
Restricting the analysis to the extended MHC locus reduced the multipletesting burden such that expression of 66% and 35% of the V α and V β genes, respectively, was significantly associated with variation in the MHC locus at a 5% FDR (Online Methods, Supplementary  Fig. 7b and Supplementary Table 4 ). The MHC locus stands out, as we observed just one other genome-wide-significant trans association with any TCR V gene (TRVB24-1, associated with variation near ZNF443) (Fig. 2a,b and Supplementary Fig. 9 ). Interestingly, despite the lack of MHC restriction of γδ TCRs 30 , the few significant associations with expression of V δ genes also mapped to the MHC locus ( Fig. 2c,d) . We speculate that these associations might be caused by the small population of δβ T cells that recognize MHC-presented peptides 30 . Notably, there were no genome-wide-significant associations between the MHC locus and the expression of immunoglobulin V genes, which encode antibodies ( Fig. 2e-g and Supplementary  Figs. 7b and 8) , and there was just one association between MHC variants and expression of any other gene (Fig. 2h) , highlighting the specific relationship between the MHC and TCR.
Classical MHC genes drive most MHC locus-TCR associations
To localize functional elements in the MHC region that associate with V α or V β gene expression, we used the genotyped SNPs to impute genotype estimates for all known MHC variants 31 (Fig. 1) . We then performed forward stepwise regression to identify independent associations with any SNPs within the MHC locus or with amino acid polymorphisms in classical MHC genes. We iteratively added polymorphic positions to a predictive model of each gene's expression until no additional position significantly improved the model fit (F test, P-value threshold = 0.05 under Bonferroni correction; Fig. 3a , Online Methods, Supplementary Fig. 10 and Supplementary Table 6 ).
Using this conservative threshold, we identified 66 independent MHC-TCR associations for 28 TCR V α and 15 V β genes. These associations explained from 2.2 to 37% of the variation in expression for each V gene ( Supplementary Fig. 11 and Supplementary Table 7) . It is often difficult to precisely locate causal sites in QTL mapping because of linkage disequilibrium (LD; the property that genotypes at linked sites tend to be correlated). Nonetheless, despite the fact that LD tends to spread association signals, we observed strong enrichment of signals within the transcribed regions of classical MHC genes, especially in HLA-DRB1. Forty-two of 66 associations were in MHC Thr/Thr Asn/Thr Asn/Asn
HLA-DRβ1 residue 77
Expression of TRAV12-2 Figure 1 Illustration of our approach. Expression of TCR V genes in peripheral blood was estimated by mapping whole-blood RNA-seq 29 reads to V genes while controlling for relevant individual-level covariates and the total number of reads mapped for each TCR chain in that individual. Genotypes were measured across the genome using the Illumina HumanOmni1-Quad BeadChip 29 . MHC genotypes were imputed with SNP2HLA 31 . Associations between nucleotide or amino acid genotypes and V gene expression were tested using Pearson correlations. nt, nucleotide; aa, amino acid.
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A r t i c l e s genes; of these, 37 associations were in class II genes and 25 associations were in the class II gene HLA-DRB1 alone (representing 3.5-fold, 7.5-fold and 15.8-fold enrichment, respectively, relative to all variants).
In addition, many of the 24 remaining associations outside genes were near classical MHC protein-encoding regions and may thus be in LD with causal variants in genes. The larger number of associations with variation in MHC class II protein-encoding regions than in MHC class I protein-encoding regions may be biologically meaningful, but this difference might also reflect greater power in our data set to detect class II interactions due to the higher abundance of CD4 + than CD8 + T cells in peripheral blood 32 .
To test the robustness of our results, we conducted two further analyses. First, we tested for independent associations using classical fourdigit MHC haplotypes instead of nucleotide and amino acid variation. This analysis yielded qualitatively similar results. Seventy-five of 92 associations were with MHC class II haplotypes; of these, 32 associations were with HLA-DRB1 haplotypes (representing 1.6-fold and 2.4-fold enrichment, respectively, relative to all classical MHC haplotypes (Supplementary Figs. 12 and 13, and Supplementary Table 8 ). HLA-DRB1*03:01 was associated with expression of the largest number of different V genes (12 genes). Second, we performed a joint multiple-phenotype regression analysis. This analysis also indicated that MHC class II genes and especially HLA-DRB1 contributed the most signals (Online Methods and Supplementary Figs. 14-16) .
To assess the specific contribution of coding variants to these associations, we used a variance-components method designed for genomic data, GCTA 33 , to estimate the fraction of the variation in expression of TCR V genes that can be explained by coding variants in classical MHC genes. We fit a model with genetic components representing the amino acid variation for each MHC gene and a component for variants in the MHC locus outside the transcribed regions of the classical MHC genes (Fig. 3b,c and Supplementary Figs. 17-22 ). We found that amino acid variants for MHC genes explained a significant fraction of variation in expression for 33 of 44 TCR V α genes and 16 of 40 V β genes and explained 92% and 88%, respectively, of the total variance in gene expression for these classes (5% FDR; Fig. 3b ,c, Online Methods and Supplementary Fig. 21) . In a negative-control analysis, only one immunoglobulin V gene of 149 was significant at a 5% FDR. For significant TCR V genes, the fraction of variance explained ranged from 5-75% (additional variance may be due to environmental or random factors, as well as measurement noise-especially for genes expressed at low levels; Supplementary Fig. 22 ). Thus, in summary, we conclude that the vast majority of the TCR expression variation explained by the MHC locus is due to amino acid variation in MHC proteins, with major contributions of MHC class II β chains and especially HLA-DRβ1.
MHC residues that bias TCR expression contact the TCR
Our next goal was to infer which amino acid positions are most likely responsible for expression biases of the TCR V genes (Online Methods). As many of the positions are in strong LD, it is often unclear which position is causal for a particular association. To quantify the uncertainty, we implemented a Bayesian Markov chain Monte Carlo (MCMC) approach that sampled over the joint distribution of potential causal positions that were consistent with the association data for each V gene. In comparison to frequentist approaches such as variable selection methods, which generally make firm choices about which sites to include, Bayesian models are generally better at quantifying and reflecting the uncertainty due to LD [34] [35] [36] [37] . Our model started with a low, uniform prior probability that any given amino acid position would be causal and incorporated the intuition that if a particular position is causal for one V gene then it may be more likely to be causal for others as well (separately for V α and V β genes). The model outputs a posterior probability that any given amino acid position is causally associated with expression of a particular V gene or with any V gene, while accounting for correlations across sites due to LD.
The results identified several MHC amino acid positions with high posterior probabilities of influencing expression of TCR V α genes ( Fig. 4 and Supplementary Table 9 ), although for some associations the posterior was shared across multiple potential causal positions in strong LD (Supplementary Fig. 23 ). Three of the top 15 amino acid positions influencing expression of TCR V α genes (HLA-DRβ1 residues 71 and 86 and HLA-DQβ1 residue 57) are strongly associated with several autoimmune diseases. Alleles for these three amino acids were strongly correlated with expression biases in TCR V α genes (Supplementary Fig. 24 ). For example, HLA-DRβ1 residue 71, the third-ranked amino acid position, is strongly associated with seropositive rheumatoid arthritis, type 1 diabetes and multiple sclerosis [38] [39] [40] . Different variants of the amino acid at this position were correlated with increased expression of different V genes. It is npg A r t i c l e s possible that biases in TCR V gene expression, previously shown to affect the outcome of autoimmunity and infection 41, 42 , are related to some MHC associations with autoimmune and infectious disease risk. Consistent with the analysis above, we found fewer positions that likely influence expression of TCR V β genes ( Supplementary Fig. 25 and Supplementary Table 10 ).
If the detected associations result from MHC residues influencing the TCR-pMHC interaction, then the relevant residues should cluster near the contact interface involved in TCR interaction with MHC or the presented peptide (influencing the TCR indirectly). A priori, MHC residues that affect TCR germline interactions could be direct pairwise structural contacts or could cause indirect effects relayed through subtle conformational changes of the MHC or peptide from within the MHC groove, as seen for alloreactive MHC in graft rejection 43 .
To test whether the associated residues tend to be at or near the TCR-pMHC interface, we first superimposed our genetic mapping results for HLA-DRβ1 residues onto protein structures of class II MHC-TCR interactions ( Fig. 5a,b ). The residues with high posterior probability of influencing V gene usage tended to be either physically near or in direct contact with the TCR in structures that contained HLA-DRβ1 ( Fig. 5d) . We next aligned structures of TCRs bound to human class II MHCs and identified all contacts between the HLA-DR, HLA-DQ or HLA-DP β chains and any of the TCR α chains or the presented peptides ( Fig. 5e and Supplementary Figs. 26  and 27 ; see the Online Methods for details). 30,000,000 31,000,000 32,000,000 33,000,000 Chromosome 6 position (12-kb bins) Number of independent significant associations TRAV8− 5  TRAV8−2  TRAV25  TRAV35  TRAV8−6  TRAV1−1  TRAV34  TRAV10  TRAV40  TRAV24  TRAV4  TRAV30  TRAV18  TRAV1−2  TRAV16  TRAV8−3  TRAV26−2  TRAV14DV4  TRAV36DV7  TRAV19  TRAV9−2  TRAV3  TRAV22  TRAV8 Values were computed using GCTA 33 . A dot indicates that the total fraction of variation explained by the MHC gene components was significant at a 5% FDR.
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A r t i c l e s Despite the large diversity in TCR α chain-MHC β chain interaction chemistries, a small subset of MHC residues contacted the TCR α chain in a large fraction of the structures, in agreement with similar analyses of TCR-MHC class I complexes 25, 44 . For example, residue 77, predicted by our model to influence TCR V α gene expression (posterior probability of 0.71), showed diverse but consistent contact with germline-encoded TCR residues in all analyzed TCR-MHC class II complexes ( Fig. 5c and Supplementary Table 11 ). To quantitatively test whether MHC amino acid residues near the TCR interaction surface tend to be associated with TCR V gene expression, we correlated our model posterior probabilities with the mean distance between the centroid for each MHC residue and the centroid for the closest TCR residue (Supplementary Fig. 28 ) or peptide residue ( Supplementary  Fig. 29 ) in all analyzed complexes. Although inter-residue proximity did not strictly correlate with energetic importance in proteinprotein interactions, we found that the association probabilities and TCR distances were significantly correlated (Pearson r = −0.28, P = 0.022; Spearman r = −0.35, P = 0.0044; Supplementary Fig. 30a ). This correlation would be higher if not for one outlier, residue 185, which may either be a false prediction or indirectly affect the structural integrity of the MHC protein 45 . The results were similar when distances between amino acid C α atoms were used instead of distances between centroids (Supplementary Fig. 30b ). Hence, our structural analysis indicates that several of the residues in close proximity to the TCR or peptide affect expression of TCR V genes.
DISCUSSION
Our results show that MHC genotype has a key role in shaping the TCR repertoire in a broad population sample, even in the absence of a shared immune challenge. We see an excess of association signals in MHC class II loci, and within HLA-DRB1 in particular; however it is unclear whether this reflects a greater role for class II genes in shaping the TCR repertoire or simply differences in power due to the greater abundance of CD4 + T cells in whole blood 32 . Many of the observed associations are linked to MHC residues, implying a direct role for protein-protein interactions in mediating these effects. We suggest that germline-encoded TCR-MHC compatibilities may bias thymic selection of some V genes relative to others, in an MHCdependent manner.
Further, we were able to fine-map some of these signals to specific amino acids that lie at the TCR-pMHC contact interface. Overall, we find evidence for the intuitive result that positions near the interaction surface have higher probability of influencing expression of V genes. That said, not all of the most strongly associated MHC positions are in direct physical contact with the TCR. More distant associations-for example, at HLA-DQβ1 residue 185-may reflect LD with other more proximal sites or may be responsible for longer-range effects within the protein complex. It is known that amino acids distal to contact interfaces do sometimes have important effects on interaction energetics, even when they are not in direct contact 45 . In particular, this has been shown previously for alloreactive MHC in graft TRAV10  TRAV1−1  TRAV1−2  TRAV12−1  TRAV12−2  TRAV12−3  TRAV13−1  TRAV13−2  TRAV14DV4  TRAV16  TRAV17  TRAV18  TRAV19  TRAV2  TRAV20  TRAV21  TRAV23DV6  TRAV24  TRAV22   181   189   231 TRAV25  TRAV26−1  TRAV26−2  TRAV27  TRAV29DV5  TRAV3  TRAV30  TRAV34  TRAV35  TRAV36DV7  TRAV38−1  TRAV38−2DV8  TRAV39  TRAV4  TRAV40  TRAV41  TRAV5  TRAV6  TRAV8 npg A r t i c l e s rejection 43 . Nonetheless, our Bayesian approach does highlight several amino acid residues positioned in the TCR-pMHC contact interface as being important for biasing V gene usage. To the best of our knowledge, these are the first examples of trans associations mediated by protein-protein interactions. Our observations also have implications for a long-standing debate about the basis of TCR specificity for MHC molecules and the molecular forces responsible for MHC restriction. In 1971, Niels Jerne postulated that germline TCR and MHC genes coevolved to be predisposed toward interacting 46 -a phenomenon also referred to as 'germline bias' . Our observation that MHC genotype has a direct association with TCR V gene usage in the broader population implies that germline-encoded TCR-MHC contacts influence interaction specificity. This orthogonal genetic evidence is in agreement with a variety of structural and functional data supporting a model of intrinsic specificity between TCR and MHC proteins. Other examples of supportive data include structural studies of numerous TCR-pMHC complexes that show persistent germline-encoded contacts between V regions and MHC molecules 20, [47] [48] [49] and compatible residues between TCR loops and HLA-A*02:01 (ref. 50). Some of these contacts are necessary for functional recognition of MHC molecules and, when mutated, can lead to drastically altered outcomes of thymic selection 20, 21 . Germline-derived V α elements have been shown to influence MHC class I versus class II selection 51 . Moreover, T cells have recently been shown to recognize MHC molecules independently of the MHC allele and peptide 27 , supplying functional evidence that the TCR has intrinsic specificity for the MHC via germline V genes. Other studies argue against the intrinsic specificity model. For example, it has been reported that specific MHC residues are not essential for TCR recognition 25 , and there are no known constraints on the CDR sequences 24 ; TCRs in mice that lack MHC class I and II molecules, CD4 and CD8 are activated by a non-MHC ligand 23 , and two TCR-pMHC structures composed of proteins from the same V genes were recently shown to have reversed polarity for MHC binding 26 . Our observations that TCR-MHC compatibilities exist within a large cohort of individuals likely reflect how most (although not necessarily all) TCR-MHC interactions occur. This leads us to view the studies that are discordant with the coevolution model as representing bona fide deviations from a 'canonical' continuum of TCR-MHC recognition modes. Some level of 'non-canonical' recognition may be expected, considering the enormous repertoire of TCR sequences possible through recombination. In summary, our genetic results are in agreement with some degree of 'hard-wired' TCR-MHC recognition and are supportive of the Jerne Hypothesis.
One key limitation of our approach is that it is based on RNA-seq analysis of peripheral whole blood. Therefore, our measurements reflect average V gene usage across different subpopulations of T cells, most notably aggregating across the CD4 + and CD8 + T cell subsets. Previous work has identified several variants in the MHC region that are associated with individual-level variation in CD4:CD8 ratios 52 ; moreover, V gene usage differs between CD4 + and CD8 + T cells 53 . Therefore, one concern is whether the variants associated with (d) Comparison of the probabilities that HLA-DRβ1 residues influence expression of any TCR V α gene (left) and the frequency with which these residues physically contact the TCR (right) in ten complexes containing HLA-DRβ1 or HLA-DRβ5. (e) Comparison of the probabilities that MHC residues influence expression of at least one TCR V α gene (maximum over HLA-DRβ1, HLA-DQβ1 and HLA-DPβ1) (left) and the frequency with which these residues physically contact the TCR (middle) and peptide (right) in 16 solved complexes (supplementary Fig. 15 ; the TCR V α protein used in each structure is listed in supplementary table 4).
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A r t i c l e s CD4:CD8 ratio might drive the signals reported here. However, we find that these SNPs are only modestly associated with our signals (Supplementary Fig. 31a,b) and are not selected by our conditional analyses ( Fig. 3a and Supplementary Figs. 12 and 15) . Controlling for these SNPs results in similar, highly significant associations with expression of V genes (Supplementary Fig. 31c,d) . Although we cannot rule out some effect on the fine-mapping, especially in the HLA-B gene, which reportedly harbors the strongest signal for CD4:CD8 ratio, the localization of high posteriors to the TCR-pMHC interface suggests that this effect is not very strong. Additionally, some measurement noise may also result from the expansion of particular T cell clones on an individual-specific basis. These and other sources of variation are implicitly modeled by our Bayesian fine-mapping approach; however, future studies with longer-read sequencing of sorted cell populations may be able to improve mapping resolution. A final concern is the possibility that we may not be able to identify causal residues that are poorly imputed. Most residues in our data have high imputation quality, and we find no correlation between imputation quality and posterior probability ( Supplementary Fig. 32 ); however, it remains possible that we may have overlooked poorly imputed causal sites.
In summary, we have found that usage of TCR V α and V β genes is associated with the genotype of MHC proteins. Our structural analysis suggests that these associations result from differences in the specificity of different TCR V genes for different MHC variants. Our results provide a compelling example of strong trans associations that are mediated by protein-protein interaction between a receptor and its ligand and shed light on the basis of TCR-MHC recognition.
URLs. International Immunogenetics Information System (IMGT), http://www.imgt.org/; RCSB Protein Data Bank (PDB), http://www.rcsb.org/.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINE METHODS
Genotype and TCR V gene expression data.
We analyzed whole-blood RNAseq and genotyping data from 922 individuals from the Depression Genes and Networks Project reported by Battle et al. 29 (National Institute of Mental Health grant 5RC2MH089916). Measured SNPs were filtered as described previously, resulting in genotype data at 649,863 SNPs 29 . The expression of each V gene relative to total chain expression was estimated from peripheral blood RNA-seq analysis (~70 million 51-bp reads per individual). Sequencing reads were mapped as in Battle et al. (using Bowtie2 (ref. 54) with TopHat 55 default parameters), and the number of unique reads that mapped to each V, J or C TCR or immunoglobulin gene was determined using a modified version of HTSeq 56 that allows reads to map to sequences of more than one V, D, J or C gene (see Supplementary Fig. 1 for the average number of reads mapped in an individual to each V gene). Individuals and genes with low read counts were removed: specifically, we removed from our analysis individuals with <80,000 reads mapping uniquely to TCR or immunoglobulin V, D, J or C genes (31% of the median). For analysis, we required that each V gene have on average >1 read per individual, at most 100 samples with zero reads and at least 1% of the individuals with at least 20 reads. Next, the read counts were log transformed (0.1 pseudoreads were added to avoid zeroes) and regressed on known technical and biological confounding factors as in Battle et al. 29 and on the log-transformed total number of reads mapped to each TCR or immunoglobulin chain (including reads that mapped to J and C genes; Supplementary Fig. 3 and Supplementary Table 1) . The median coefficient of variation for each V gene was 6% (Supplementary Fig. 3) . Finally, to avoid the effect of outliers, the residuals were quantile normalized to a normal distribution (although in practice this made little difference to the detected associations). Similar methodology was applied to immunoglobulin V genes. The final data set contained measurements for 44 TCR V α , 40 TCR V β , 11 TCR V γ , 3 TCR V δ , 31 immunoglobulin V κ , 38 immunoglobulin V λ and 41 immunoglobulin V H genes in 895 individuals.
As read mappability may vary by genotype, we analyzed the mappability of 25-mers from the reference and imputed alternative haplotypes (Supplementary Fig. 6 ). We found that in nine V genes >0% and up to 10% of 25-mers had better mappability in the reference sequence than in alternative haplotypes. We thus excluded all of these genes from the short-range (cis) association analysis (thus dropping six, one and three TCR V α , V β and V γ genes, respectively). We note that mapping differences may increase measurement noise and reduce power for detecting long-range (trans) associations, but they should not create false positives; therefore, these genes were not removed from the trans analysis. Moreover, we avoided comparing expression of different V genes, as it is difficult to estimate the mappable lengths of the V genes because of possible differences between the partial digestion of V genes and J gene pairing during V(D)J recombination. eQTL detection. Associations between genotypes and TCR V gene normalized expression values were tested using Pearson correlations. Similarly, in testing for trans associations between MHC and other genes, we used Pearson correlations to test all genes at least 1 Mb away from the MHC locus against all variants genotyped in the extended MHC locus. The extended MHC locus is defined as the region from the SLC17A2 gene at the telomeric end to the DAXX gene at the centromeric end of chromosome 6 (hg19 coordinates 25,912,984-33,290,793) 57 . For genome-wide trans-QTL mapping, we used a significance threshold of P < 5 × 10 −8 , which accounts for genome-wide significance testing.
Identification of V genes that are significantly associated with genotypes in cis or in the MHC locus. The empirical significance of the association between the expression of each V gene and short-range (cis) or MHC locus genotype was evaluated by comparing the P value of the most significantly associated SNP to the most significant P values in each of 10,000 random permutations of expression values across individuals. A threshold of 5% FDR was then used to control for the testing of multiple V genes (Supplementary Fig. 7) . The SNPs used for the cis analysis were imputed using SHAPEIT 58 (for prephasing) and IMPUTE2 (ref. 59 ). The 1000 Genomes Project Phase 1 (ref. 60) panel was used for imputation, requiring European (EUR) minor allele frequency (MAF) >0.01 and genotype likelihood >0.9. In testing for trans associations with MHC genotypes, we used genotyped SNPs within the extended MHC locus 57 .
Imputation of MHC locus genotypes. SNP2HLA 31 was used to impute the MHC locus genotypes, with a reference panel of 5,225 individuals of European descent collected by the Type 1 Diabetes Genetics Consortium 31 . The software imputes two-and four-digit classical alleles for HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1 and HLA-DPB1 and their corresponding amino acid polymorphisms and SNPs (Fig. 1, bottom) . SNPs and polymorphic amino acids with a maximum allele frequency >97.5 and alleles with a frequency <0.5% were removed. The imputation quality (Beagle r 2 value with predicted true genotypes) was higher than 0.95 and 0.99 for 97% and 80% of the imputed amino acids, respectively (excluding alleles with MAF <2.5%). There was no significant correlation between the imputation quality of amino acid residues and the posterior probability that these residues influence expression of TCR V genes (Supplementary Fig. 3 ).
Conditional analysis of associations between expression of TCR V  and V  genes and genetic variation in the MHC locus.
The imputed genotype of each variable amino acid position or nucleotide position was encoded by allelic dosage variables while omitting the most common allele (a similar encoding was used by Raychaudhuri et al. 38 ). Conditional analysis was performed separately for each V gene using forward stepwise linear regression. In each step of the regression and for every amino acid residue or nucleotide position, we considered an expanded model that included the allelic dosage variables for that position. The significance was tested using F tests. If the most significant position had a P value <0.05/n, where n was the number of tested positions, then this position was added to the model as a covariate. Regression stopped when the P value of the most significant position was greater than 0.05/n (this threshold was P ~1 × 10 −5 ). We performed two additional variations of this type of analysis. First, instead of testing for associations with nucleotide or amino acid positions in the MHC locus, we tested for associations with four-digit classical MHC haplotypes. Second, instead of testing for associations of MHC genetic variability (at the position or four-digit-haplotype level) with expression of each V gene separately, we tested for associations with joint expression of all V genes from a single chain. As the expression for each gene was quantile normalized to a normal distribution, using the joint expression of V genes gives equal weight to explaining the expression of each gene in the chain.
Estimating the fraction of variation in expression for each TCR V gene that is explained by genetic variation in the MHC proteins.
We used the GCTA tool developed by Yang et al. 33 . We fit a model with a component for each variable classical MHC protein (HLA-A, HLA-B, HLA-C, HLA-DRβ1, HLA-DQα1, HLA-DQβ1, HLA-DPα1 and HLA-DPβ1) representing the variability at the amino acid level and a component for all SNPs in the MHC locus outside the transcribed regions of the classical MHC genes. Amino acid-level variation is used in place of genotype because the annotation of transcribed SNPs in MHC genes is often ambiguous and allele dependent. To adapt GCTA to multiallelic positions, we calculated the genetic relationship between individuals at a multiallelic position by averaging the relationship over dosage variables for all possible alleles. To estimate the significance of the total variation explained by the MHC protein components, we ran GCTA on 100 permutations of the expression data for each TCR V gene. The fraction of variation explained for these permuted expression vectors follows a truncated normal distribution 61 . We estimated the variance of this distribution and used it to compute a P value for the fraction of variation in the expression of each TCR V gene that was explained by genetic variation in MHC proteins. We corrected for multiplehypothesis testing using a 5% FDR 62 .
Inferring which MHC protein amino acid residues are associated with expression biases of TCR V genes. Identifying which amino acid residues drive associations of MHC proteins with the expression of TCR V genes is challenging because of the LD between nearby variants. To test the association of each residue while accounting for the genotype of other residues, we used a Bayesian variable selection approach with a spike-and-slab prior 63, 64 . The Bayesian modeling framework has a number of practical advantages for this problem: in particular, it allows us to appropriately account for the joint uncertainty when there are multiple causal positions and extensive LD. We used priors that reflected our expectation that most residues do not directly influence expression and that a residue that influences expression of one V gene is more likely to be relevant for expression of other V genes. The priors were set such that the model required strong evidence to return high posterior probabilities of association.
Specifically, we modeled the expression of each V α or V β gene as a linear combination of the imputed alleles of amino acid residues of classical MHC genes. Each residue's allelic dosage variable can either be included in the model or excluded (coefficient = 0) from the model of expression for each V gene. We sampled the space of possible models to estimate the posterior probability that each residue has at least one of its allelic dosage variables in the model of a specific V gene. Assuming that associations are caused by the effects of residues on V gene expression, we refer to this posterior as the probability that a residue influences expression of a TCR V gene.
In detail, our response vectors are the relative expression of each V gene from a specific chain across the N = 895 individuals. For a TCR chain with T paralogous V genes, we define a multiple-response matrix Y N × T with y i,t being the standardized relative expression of TCR V gene t ∈{1,2,…,T} in individual i ∈{1,2,…,N}. Our features are the imputed amino acid residues in each individual for each of the classical MHC genes (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1 and HLA-DPB1). The allelic dosage of a specific amino acid variant (a ∈{1,2,…,A r }) of residue r of MHC gene g in individual i is represented by a continuous variable (x i,(g,r,a) ∈ [0,2]). For clarity, we also use below h ∈{1,2,…,H} as the index for all possible combinations of (g,r,a). Our genotype matrix is therefore X N × H . We filtered out residues in which the maximal allele frequency was greater than 97.5% and dropped alleles with frequency lower than 0.5%. We define z t,h ∈{0,1} to be an indicator of whether genotype x h is included (has a coefficient β t,h ~N(0, s b 2 )) or excluded (has a zero coefficient) from the model of y t .
Together, the expression of gene t in individual i is modeled by Previous structural analysis of TCR-pMHC complexes has found that a limited and consistent set of MHC residues interacts with the TCR and the docking orientation of the TCR is semiconserved. This is reflected by the choice of the prior probability of z t,h = 1 to be small and shared across V genes (p(z t,h = 1) = p h , for t ∈{1,2,…,T}) and the modeling of α-chain and β-chain genes separately. We consider that residue r of gene g influences the expression of TCR V gene t if at least one of the allelic dosage variables that represent it is in the model (its indicator variable z t,(g,r,a) is equal to 1). We denote this event F(Z,t,g,r) as 
( )
To avoid an a priori preference for residues with different numbers of possible alleles, we modified the prior beta distribution parameters of the indicator prior π h in equation (3) such that the a priori expectation and
(2) (2)
(4) (4)
variance of F(Z,t,g,r) are equal for residues with different numbers of possible variants and match the prior in equation (3) ( ( , , , )) ( ( , , , )), (( , ) F Z t g r F Z t g r g r 1 1 2 2 1 1 = ∀ n nd ( , )) g r 2 2 To find suitable values for the prior parameters, we assume that x h is an allelic dosage variable of a residue r that has only two possible alleles and therefore is represented by a single dosage variable. We define π h ~Beta(a,b) to be the prior of z h ~Ber(π h ). Now, let x h* be one of A dosage variables that represent a residue r* and π h* ~Beta(a*,b*) be the prior of z h* ~Ber(π h* ). We seek (a*,b*) such that the a priori expectation and variance of F over residue r* are equal to the expectation and variance of F over residue r.
E E prior prior( ( , , , )) ( ( , , *, *)) F Z t g r F Z t g r =
Var
( ( )) Var ( *)) prior priorF Z t g r F Z t g r , , , ( , , *, = Equation (8) We then solved equations (12) and (13) numerically using the R nleqslv package to achieve (a*,b*) for various values of A.
In our analyses, the prior probability of any MHC residue interacting with a specific TCR V gene was set at 0.1%, and the prior probability of each position of the MHC interacting with any of the 44 V α and 40 V β genes was 4.3% and 3.9%, respectively.
To compute the posterior probabilities with which each MHC residue influences TCR V gene expression (that is, E θ|X,Y (F(Z,t,g,r)) for all r), we sampled the space of possible models using an efficient Gibbs sampler 65 where the likelihood is integrated over the coefficients (β) ( ) = ( ) = ( ) ( ) ∫ Altogether, we sampled 100,000 samples from ten different starting points (excluding the first 2,000 samples).
Structural analysis.
A full list of TCR-pMHC structures and intermolecular interactions is curated by the International Immunogenetics Information System (IMGT) 66 . We used all structures that were available in PDB 67 on 15 June 2015. To compare intermolecular interactions to genetic analysis, IMGT numbering was converted to PDB numbering for all residues (PDB is indexed in the same manner as proteins in the UniProt database 68 ). For the structure 4P4K, we converted the PDB numbering for the HLA-DP residues to the HLA-DQ and HLA-DR numbering using IMGT labeling (for example, residue 72AG in the IMGT numbering equates to PDB residue 75 for HLA-DP structures, but residue 77 for all HLA-DP and HLA-DQ structures). This allowed for a more consistent comparison between the different alleles. The IMGT structural contact algorithm determined the structural contacts, which were defined as polar, non-polar and hydrogen bonds. npg Pairwise distance analysis. The distance between a pair of amino acid residues were calculated as the distance between the centroids of the amino acids using PDB xyz coordinates for every atom in a given amino acid. This calculation accounts for directionality of the side chains in the structure. For each MHC β-chain residue, the minimum distance to any TCR α-chain residue and the minimum distance to every peptide residue were calculated. For comparison, we also calculated the distance between the C α atom of the residues using the PDB xyz coordinates of the C α atoms (Supplementary Fig. 28b) . The results using the two distance measurements were similar. A list of the PDB files used can be found in Supplementary Table 11 .
